GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb7
|
ENSMUSG00000038721.9 | homeobox B7 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb7 | mm39_v1_chr11_+_96177449_96177480 | -0.19 | 2.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_150341911 | 13.49 |
ENSMUST00000162367.8
ENSMUST00000161611.8 ENSMUST00000161320.8 ENSMUST00000159035.2 |
Prg4
|
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
chrM_+_5319 | 10.52 |
ENSMUST00000082402.1
|
mt-Co1
|
mitochondrially encoded cytochrome c oxidase I |
chr19_+_39275518 | 10.43 |
ENSMUST00000003137.15
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr3_+_59989282 | 8.24 |
ENSMUST00000029326.6
|
Sucnr1
|
succinate receptor 1 |
chr10_+_87695117 | 8.21 |
ENSMUST00000105300.9
|
Igf1
|
insulin-like growth factor 1 |
chr19_+_26582450 | 8.18 |
ENSMUST00000176769.9
ENSMUST00000208163.2 ENSMUST00000025862.15 ENSMUST00000176030.8 |
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr7_+_51537645 | 7.64 |
ENSMUST00000208711.2
|
Gas2
|
growth arrest specific 2 |
chr1_+_127657142 | 7.64 |
ENSMUST00000038006.8
|
Acmsd
|
amino carboxymuconate semialdehyde decarboxylase |
chr15_+_6474808 | 7.33 |
ENSMUST00000022749.17
ENSMUST00000239466.2 |
C9
|
complement component 9 |
chr10_+_87694924 | 7.03 |
ENSMUST00000095360.11
|
Igf1
|
insulin-like growth factor 1 |
chr2_+_102488985 | 6.93 |
ENSMUST00000080210.10
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr19_+_40078132 | 6.75 |
ENSMUST00000068094.13
ENSMUST00000080171.3 |
Cyp2c50
|
cytochrome P450, family 2, subfamily c, polypeptide 50 |
chr3_+_138121245 | 6.69 |
ENSMUST00000161312.8
ENSMUST00000013458.9 |
Adh4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr8_-_85500010 | 6.55 |
ENSMUST00000109764.8
|
Nfix
|
nuclear factor I/X |
chr5_-_87240405 | 6.50 |
ENSMUST00000132667.2
ENSMUST00000145617.8 ENSMUST00000094649.11 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr16_+_42727926 | 6.45 |
ENSMUST00000151244.8
ENSMUST00000114694.9 |
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr11_-_84058292 | 6.40 |
ENSMUST00000050771.8
|
Gm11437
|
predicted gene 11437 |
chr19_-_44396092 | 6.35 |
ENSMUST00000041331.4
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr5_-_89605622 | 6.31 |
ENSMUST00000049209.13
|
Gc
|
vitamin D binding protein |
chrM_+_10167 | 6.14 |
ENSMUST00000082414.1
|
mt-Nd4
|
mitochondrially encoded NADH dehydrogenase 4 |
chr19_+_26725589 | 6.08 |
ENSMUST00000207812.2
ENSMUST00000175791.9 ENSMUST00000207118.2 ENSMUST00000209085.2 ENSMUST00000112637.10 ENSMUST00000207054.2 ENSMUST00000208589.2 ENSMUST00000176475.9 ENSMUST00000176698.9 ENSMUST00000207832.2 ENSMUST00000177252.9 ENSMUST00000208712.2 ENSMUST00000208186.2 ENSMUST00000208806.2 ENSMUST00000208027.2 |
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr10_+_116111441 | 6.07 |
ENSMUST00000218553.2
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chrM_+_11735 | 5.92 |
ENSMUST00000082418.1
|
mt-Nd5
|
mitochondrially encoded NADH dehydrogenase 5 |
chr19_+_46120327 | 5.68 |
ENSMUST00000043739.6
ENSMUST00000237098.2 |
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr10_+_127734384 | 5.36 |
ENSMUST00000047134.8
|
Sdr9c7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
chr6_-_138056914 | 5.15 |
ENSMUST00000171804.4
|
Slc15a5
|
solute carrier family 15, member 5 |
chr1_+_167426019 | 5.14 |
ENSMUST00000111386.8
ENSMUST00000111384.8 |
Rxrg
|
retinoid X receptor gamma |
chr8_+_46080746 | 5.10 |
ENSMUST00000145458.9
ENSMUST00000134321.8 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chrM_+_8603 | 5.06 |
ENSMUST00000082409.1
|
mt-Co3
|
mitochondrially encoded cytochrome c oxidase III |
chr10_-_108846816 | 5.01 |
ENSMUST00000105276.8
ENSMUST00000064054.14 |
Syt1
|
synaptotagmin I |
chr18_+_20380397 | 4.98 |
ENSMUST00000054128.7
|
Dsg1c
|
desmoglein 1 gamma |
chr8_-_72966840 | 4.97 |
ENSMUST00000238973.2
|
Cib3
|
calcium and integrin binding family member 3 |
chrM_+_9870 | 4.92 |
ENSMUST00000084013.1
|
mt-Nd4l
|
mitochondrially encoded NADH dehydrogenase 4L |
chr19_-_40062174 | 4.87 |
ENSMUST00000048959.5
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr10_+_87694117 | 4.85 |
ENSMUST00000122386.8
|
Igf1
|
insulin-like growth factor 1 |
chr1_+_130754413 | 4.79 |
ENSMUST00000027675.14
ENSMUST00000133792.8 |
Pigr
|
polymeric immunoglobulin receptor |
chr19_+_58658779 | 4.66 |
ENSMUST00000057270.9
|
Pnlip
|
pancreatic lipase |
chr7_+_51528788 | 4.63 |
ENSMUST00000107591.9
|
Gas2
|
growth arrest specific 2 |
chr8_+_45960804 | 4.57 |
ENSMUST00000067065.14
ENSMUST00000124544.8 ENSMUST00000138049.9 ENSMUST00000132139.9 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr19_+_24853039 | 4.57 |
ENSMUST00000073080.7
|
Gm10053
|
predicted gene 10053 |
chr5_-_87572060 | 4.52 |
ENSMUST00000072818.6
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chrM_+_9459 | 4.52 |
ENSMUST00000082411.1
|
mt-Nd3
|
mitochondrially encoded NADH dehydrogenase 3 |
chr4_-_104733580 | 4.48 |
ENSMUST00000064873.9
ENSMUST00000106808.10 ENSMUST00000048947.15 |
C8a
|
complement component 8, alpha polypeptide |
chr6_-_141892517 | 4.45 |
ENSMUST00000168119.8
|
Slco1a1
|
solute carrier organic anion transporter family, member 1a1 |
chr1_-_139708906 | 4.31 |
ENSMUST00000111986.8
ENSMUST00000027612.11 ENSMUST00000111989.9 |
Cfhr4
|
complement factor H-related 4 |
chrM_+_14138 | 4.30 |
ENSMUST00000082421.1
|
mt-Cytb
|
mitochondrially encoded cytochrome b |
chr16_-_23807602 | 4.30 |
ENSMUST00000023151.6
|
Bcl6
|
B cell leukemia/lymphoma 6 |
chr1_-_136888118 | 4.24 |
ENSMUST00000192357.6
ENSMUST00000027649.14 |
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr1_+_67162176 | 4.20 |
ENSMUST00000027144.8
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr18_+_12776358 | 4.15 |
ENSMUST00000234966.2
ENSMUST00000025294.9 |
Ttc39c
|
tetratricopeptide repeat domain 39C |
chr6_-_141801897 | 4.10 |
ENSMUST00000165990.8
|
Slco1a4
|
solute carrier organic anion transporter family, member 1a4 |
chr19_-_8382424 | 4.04 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
chr19_+_58658838 | 4.03 |
ENSMUST00000238108.2
|
Pnlip
|
pancreatic lipase |
chr10_-_115198093 | 4.01 |
ENSMUST00000219890.2
ENSMUST00000218731.2 ENSMUST00000217887.2 ENSMUST00000092170.7 |
Tmem19
|
transmembrane protein 19 |
chr8_-_93806593 | 3.98 |
ENSMUST00000109582.3
|
Ces1b
|
carboxylesterase 1B |
chr1_-_165762469 | 3.98 |
ENSMUST00000069609.12
ENSMUST00000111427.9 ENSMUST00000111426.11 |
Pou2f1
|
POU domain, class 2, transcription factor 1 |
chr2_+_70305267 | 3.97 |
ENSMUST00000100043.3
|
Sp5
|
trans-acting transcription factor 5 |
chrM_-_14061 | 3.89 |
ENSMUST00000082419.1
|
mt-Nd6
|
mitochondrially encoded NADH dehydrogenase 6 |
chr14_+_28740162 | 3.87 |
ENSMUST00000055662.4
|
Lrtm1
|
leucine-rich repeats and transmembrane domains 1 |
chr6_-_138013901 | 3.87 |
ENSMUST00000150278.3
|
Slc15a5
|
solute carrier family 15, member 5 |
chr3_-_107925159 | 3.84 |
ENSMUST00000004140.11
|
Gstm1
|
glutathione S-transferase, mu 1 |
chrX_+_10118544 | 3.77 |
ENSMUST00000049910.13
|
Otc
|
ornithine transcarbamylase |
chr8_-_68427217 | 3.72 |
ENSMUST00000098696.10
ENSMUST00000038959.16 ENSMUST00000093469.11 |
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chr1_-_121260298 | 3.72 |
ENSMUST00000071064.13
|
Insig2
|
insulin induced gene 2 |
chr3_+_146302832 | 3.67 |
ENSMUST00000029837.14
ENSMUST00000147409.2 ENSMUST00000121133.2 |
Uox
|
urate oxidase |
chrX_+_59044796 | 3.61 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr2_+_67935015 | 3.61 |
ENSMUST00000042456.4
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr10_-_24803336 | 3.61 |
ENSMUST00000020161.10
|
Arg1
|
arginase, liver |
chrM_+_3906 | 3.54 |
ENSMUST00000082396.1
|
mt-Nd2
|
mitochondrially encoded NADH dehydrogenase 2 |
chr5_+_42225303 | 3.51 |
ENSMUST00000087332.5
|
Gm16223
|
predicted gene 16223 |
chr8_+_46080840 | 3.46 |
ENSMUST00000135336.9
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr10_+_87695352 | 3.44 |
ENSMUST00000121952.8
ENSMUST00000126490.8 |
Igf1
|
insulin-like growth factor 1 |
chr1_-_140111018 | 3.43 |
ENSMUST00000192880.6
ENSMUST00000111977.8 |
Cfh
|
complement component factor h |
chr10_-_115197775 | 3.40 |
ENSMUST00000217848.2
|
Tmem19
|
transmembrane protein 19 |
chr5_+_135135735 | 3.38 |
ENSMUST00000201977.4
ENSMUST00000005507.10 |
Mlxipl
|
MLX interacting protein-like |
chr3_+_41517790 | 3.31 |
ENSMUST00000163764.8
|
Jade1
|
jade family PHD finger 1 |
chr2_-_34951443 | 3.28 |
ENSMUST00000028233.7
|
Hc
|
hemolytic complement |
chr5_-_66238313 | 3.27 |
ENSMUST00000202700.4
ENSMUST00000094757.9 ENSMUST00000113724.6 |
Rbm47
|
RNA binding motif protein 47 |
chr6_+_141575226 | 3.27 |
ENSMUST00000042812.9
|
Slco1b2
|
solute carrier organic anion transporter family, member 1b2 |
chr1_+_167425953 | 3.25 |
ENSMUST00000015987.10
|
Rxrg
|
retinoid X receptor gamma |
chr3_+_134986982 | 3.25 |
ENSMUST00000120397.8
ENSMUST00000029817.11 |
Bdh2
|
3-hydroxybutyrate dehydrogenase, type 2 |
chrX_+_10118600 | 3.24 |
ENSMUST00000115528.3
|
Otc
|
ornithine transcarbamylase |
chr5_+_90666791 | 3.19 |
ENSMUST00000113179.9
ENSMUST00000128740.2 |
Afm
|
afamin |
chr3_-_75177378 | 3.15 |
ENSMUST00000039047.5
|
Serpini2
|
serine (or cysteine) peptidase inhibitor, clade I, member 2 |
chr15_+_4756684 | 3.13 |
ENSMUST00000161997.8
ENSMUST00000022788.15 |
C6
|
complement component 6 |
chr1_-_162726234 | 3.09 |
ENSMUST00000111510.8
ENSMUST00000045902.13 |
Fmo2
|
flavin containing monooxygenase 2 |
chr15_+_4756657 | 3.08 |
ENSMUST00000162585.8
|
C6
|
complement component 6 |
chr8_+_45960931 | 3.05 |
ENSMUST00000171337.10
ENSMUST00000067107.15 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr12_+_59142439 | 3.04 |
ENSMUST00000219140.3
|
Mia2
|
MIA SH3 domain ER export factor 2 |
chr15_+_10314173 | 3.03 |
ENSMUST00000127467.3
|
Prlr
|
prolactin receptor |
chr1_-_140111138 | 3.00 |
ENSMUST00000111976.9
ENSMUST00000066859.13 |
Cfh
|
complement component factor h |
chr1_-_121260274 | 2.95 |
ENSMUST00000161068.2
|
Insig2
|
insulin induced gene 2 |
chr8_-_5155347 | 2.94 |
ENSMUST00000023835.3
|
Slc10a2
|
solute carrier family 10, member 2 |
chr6_+_34575435 | 2.93 |
ENSMUST00000079391.10
ENSMUST00000142512.8 ENSMUST00000115027.8 ENSMUST00000115026.8 |
Cald1
|
caldesmon 1 |
chr7_-_73191484 | 2.92 |
ENSMUST00000197642.2
ENSMUST00000026895.14 ENSMUST00000169922.9 |
Chd2
|
chromodomain helicase DNA binding protein 2 |
chr3_+_41517829 | 2.90 |
ENSMUST00000170711.8
|
Jade1
|
jade family PHD finger 1 |
chr3_-_107925122 | 2.87 |
ENSMUST00000126593.3
|
Gstm1
|
glutathione S-transferase, mu 1 |
chr4_+_102446883 | 2.87 |
ENSMUST00000097949.11
ENSMUST00000106901.2 |
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr6_-_144155197 | 2.84 |
ENSMUST00000038815.14
ENSMUST00000111749.8 ENSMUST00000170367.9 |
Sox5
|
SRY (sex determining region Y)-box 5 |
chr17_-_79292856 | 2.81 |
ENSMUST00000118991.2
|
Prkd3
|
protein kinase D3 |
chr6_+_29859372 | 2.78 |
ENSMUST00000115238.10
|
Ahcyl2
|
S-adenosylhomocysteine hydrolase-like 2 |
chr16_+_43067641 | 2.76 |
ENSMUST00000079441.13
ENSMUST00000114691.8 |
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr1_-_130589349 | 2.75 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr1_-_130589321 | 2.74 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr3_-_116506294 | 2.73 |
ENSMUST00000029569.9
|
Slc35a3
|
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3 |
chr11_-_5900019 | 2.73 |
ENSMUST00000102920.4
|
Gck
|
glucokinase |
chrX_-_59449137 | 2.71 |
ENSMUST00000033480.13
ENSMUST00000101527.3 |
Atp11c
|
ATPase, class VI, type 11C |
chrX_-_74886623 | 2.69 |
ENSMUST00000114057.8
|
Pls3
|
plastin 3 (T-isoform) |
chr1_+_177272215 | 2.64 |
ENSMUST00000192851.2
ENSMUST00000193480.2 ENSMUST00000195388.2 |
Zbtb18
|
zinc finger and BTB domain containing 18 |
chr18_+_84106796 | 2.64 |
ENSMUST00000235383.2
|
Zadh2
|
zinc binding alcohol dehydrogenase, domain containing 2 |
chr9_+_53212871 | 2.63 |
ENSMUST00000051014.2
|
Exph5
|
exophilin 5 |
chr7_+_51528715 | 2.61 |
ENSMUST00000051912.13
|
Gas2
|
growth arrest specific 2 |
chr3_-_146302343 | 2.59 |
ENSMUST00000029836.9
|
Dnase2b
|
deoxyribonuclease II beta |
chr1_+_177273226 | 2.59 |
ENSMUST00000077225.8
|
Zbtb18
|
zinc finger and BTB domain containing 18 |
chr6_-_71376277 | 2.58 |
ENSMUST00000149415.2
|
Rmnd5a
|
required for meiotic nuclear division 5 homolog A |
chr5_+_90608751 | 2.57 |
ENSMUST00000031314.10
|
Alb
|
albumin |
chr19_-_34855278 | 2.57 |
ENSMUST00000112460.3
|
Pank1
|
pantothenate kinase 1 |
chr6_+_125298372 | 2.55 |
ENSMUST00000176442.8
ENSMUST00000177329.2 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr1_-_14374794 | 2.55 |
ENSMUST00000190337.7
|
Eya1
|
EYA transcriptional coactivator and phosphatase 1 |
chr3_+_29568055 | 2.54 |
ENSMUST00000140288.2
|
Egfem1
|
EGF-like and EMI domain containing 1 |
chr15_+_92495007 | 2.54 |
ENSMUST00000035399.10
|
Pdzrn4
|
PDZ domain containing RING finger 4 |
chr15_-_60793115 | 2.54 |
ENSMUST00000096418.5
|
A1bg
|
alpha-1-B glycoprotein |
chr4_+_13751297 | 2.53 |
ENSMUST00000105566.9
|
Runx1t1
|
RUNX1 translocation partner 1 |
chrM_+_7779 | 2.52 |
ENSMUST00000082408.1
|
mt-Atp6
|
mitochondrially encoded ATP synthase 6 |
chr18_+_36431732 | 2.50 |
ENSMUST00000210490.3
|
Igip
|
IgA inducing protein |
chr14_+_66207163 | 2.48 |
ENSMUST00000153460.8
|
Clu
|
clusterin |
chr14_-_64654397 | 2.47 |
ENSMUST00000210428.2
|
Msra
|
methionine sulfoxide reductase A |
chr19_+_37686240 | 2.46 |
ENSMUST00000025946.7
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1 |
chr5_-_108022900 | 2.43 |
ENSMUST00000138111.8
ENSMUST00000112642.8 |
Evi5
|
ecotropic viral integration site 5 |
chr4_+_98919183 | 2.43 |
ENSMUST00000030280.7
|
Angptl3
|
angiopoietin-like 3 |
chr15_-_50753792 | 2.41 |
ENSMUST00000185183.2
|
Trps1
|
transcriptional repressor GATA binding 1 |
chr18_-_3281089 | 2.40 |
ENSMUST00000139537.2
ENSMUST00000124747.8 |
Crem
|
cAMP responsive element modulator |
chr19_-_39451509 | 2.40 |
ENSMUST00000035488.3
|
Cyp2c38
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
chr2_+_22959452 | 2.40 |
ENSMUST00000155602.4
|
Acbd5
|
acyl-Coenzyme A binding domain containing 5 |
chr2_-_77349909 | 2.39 |
ENSMUST00000111830.9
|
Zfp385b
|
zinc finger protein 385B |
chr15_+_7120089 | 2.39 |
ENSMUST00000228723.2
|
Lifr
|
LIF receptor alpha |
chr10_-_12490424 | 2.38 |
ENSMUST00000217994.2
|
Utrn
|
utrophin |
chr6_+_17491231 | 2.36 |
ENSMUST00000080469.12
|
Met
|
met proto-oncogene |
chr18_+_69633741 | 2.36 |
ENSMUST00000207214.2
ENSMUST00000201094.4 ENSMUST00000200703.4 ENSMUST00000202765.4 |
Tcf4
|
transcription factor 4 |
chr3_+_129630380 | 2.36 |
ENSMUST00000077918.7
|
Cfi
|
complement component factor i |
chr2_+_58645189 | 2.35 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr1_-_14374842 | 2.35 |
ENSMUST00000188857.7
ENSMUST00000185453.7 |
Eya1
|
EYA transcriptional coactivator and phosphatase 1 |
chr16_+_22926504 | 2.34 |
ENSMUST00000187168.7
ENSMUST00000232287.2 ENSMUST00000077605.12 |
Eif4a2
|
eukaryotic translation initiation factor 4A2 |
chr19_+_31846154 | 2.33 |
ENSMUST00000224564.2
ENSMUST00000224304.2 ENSMUST00000075838.8 ENSMUST00000224400.2 |
A1cf
|
APOBEC1 complementation factor |
chr17_+_44263890 | 2.30 |
ENSMUST00000177857.9
ENSMUST00000044792.6 |
Rcan2
|
regulator of calcineurin 2 |
chr13_-_53627110 | 2.28 |
ENSMUST00000021922.10
|
Msx2
|
msh homeobox 2 |
chr14_+_51333816 | 2.26 |
ENSMUST00000169895.3
|
Rnase4
|
ribonuclease, RNase A family 4 |
chr17_+_3447465 | 2.25 |
ENSMUST00000072156.7
|
Tiam2
|
T cell lymphoma invasion and metastasis 2 |
chr7_+_51530060 | 2.25 |
ENSMUST00000145049.2
|
Gas2
|
growth arrest specific 2 |
chr8_-_93924426 | 2.22 |
ENSMUST00000034172.8
|
Ces1d
|
carboxylesterase 1D |
chr2_+_58644922 | 2.22 |
ENSMUST00000059102.13
|
Upp2
|
uridine phosphorylase 2 |
chr2_-_34990689 | 2.22 |
ENSMUST00000226631.2
ENSMUST00000045776.5 ENSMUST00000226972.2 |
AI182371
|
expressed sequence AI182371 |
chr16_+_22926162 | 2.22 |
ENSMUST00000023599.13
ENSMUST00000168891.8 |
Eif4a2
|
eukaryotic translation initiation factor 4A2 |
chr19_-_34855242 | 2.21 |
ENSMUST00000238065.2
|
Pank1
|
pantothenate kinase 1 |
chr1_+_179788675 | 2.21 |
ENSMUST00000076687.12
ENSMUST00000097450.10 ENSMUST00000212756.2 |
Cdc42bpa
|
CDC42 binding protein kinase alpha |
chr3_-_95811993 | 2.19 |
ENSMUST00000147962.3
ENSMUST00000036181.15 |
Car14
|
carbonic anhydrase 14 |
chrX_-_50106844 | 2.17 |
ENSMUST00000053593.8
|
Rap2c
|
RAP2C, member of RAS oncogene family |
chr18_-_66155651 | 2.15 |
ENSMUST00000143990.2
|
Lman1
|
lectin, mannose-binding, 1 |
chr19_-_7943365 | 2.15 |
ENSMUST00000182102.8
ENSMUST00000075619.5 |
Slc22a27
|
solute carrier family 22, member 27 |
chr2_+_132689640 | 2.14 |
ENSMUST00000124836.8
ENSMUST00000154160.2 |
Crls1
|
cardiolipin synthase 1 |
chr6_-_101176147 | 2.13 |
ENSMUST00000239140.2
|
Pdzrn3
|
PDZ domain containing RING finger 3 |
chr14_-_4488167 | 2.13 |
ENSMUST00000022304.12
|
Thrb
|
thyroid hormone receptor beta |
chr8_-_41469786 | 2.12 |
ENSMUST00000117735.8
|
Mtus1
|
mitochondrial tumor suppressor 1 |
chr10_-_12424623 | 2.12 |
ENSMUST00000219003.2
|
Utrn
|
utrophin |
chr10_-_68114543 | 2.10 |
ENSMUST00000219238.2
|
Arid5b
|
AT rich interactive domain 5B (MRF1-like) |
chr7_-_12731594 | 2.10 |
ENSMUST00000133977.3
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr7_+_119499322 | 2.08 |
ENSMUST00000106516.2
|
Lyrm1
|
LYR motif containing 1 |
chr9_+_120758282 | 2.07 |
ENSMUST00000130466.8
|
Ctnnb1
|
catenin (cadherin associated protein), beta 1 |
chr3_-_131138541 | 2.07 |
ENSMUST00000090246.5
ENSMUST00000126569.2 |
Sgms2
|
sphingomyelin synthase 2 |
chr5_-_145946408 | 2.07 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr18_-_35760260 | 2.06 |
ENSMUST00000025212.8
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr9_+_32027335 | 2.05 |
ENSMUST00000174641.8
|
Arhgap32
|
Rho GTPase activating protein 32 |
chr6_+_125298296 | 2.04 |
ENSMUST00000081440.14
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr6_-_116050081 | 2.02 |
ENSMUST00000173548.3
|
Tmcc1
|
transmembrane and coiled coil domains 1 |
chr1_+_13738967 | 2.02 |
ENSMUST00000088542.4
|
Xkr9
|
X-linked Kx blood group related 9 |
chr2_-_7086018 | 2.01 |
ENSMUST00000114923.3
ENSMUST00000182706.8 |
Celf2
|
CUGBP, Elav-like family member 2 |
chr1_+_21310803 | 2.01 |
ENSMUST00000027067.15
|
Gsta3
|
glutathione S-transferase, alpha 3 |
chr15_+_54975713 | 1.99 |
ENSMUST00000096433.10
|
Deptor
|
DEP domain containing MTOR-interacting protein |
chr1_+_21310821 | 1.98 |
ENSMUST00000121676.8
ENSMUST00000124990.3 |
Gsta3
|
glutathione S-transferase, alpha 3 |
chr3_+_62327089 | 1.97 |
ENSMUST00000161057.2
|
Arhgef26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr19_+_37425180 | 1.96 |
ENSMUST00000128184.3
|
Hhex
|
hematopoietically expressed homeobox |
chr2_+_22959223 | 1.95 |
ENSMUST00000114523.10
|
Acbd5
|
acyl-Coenzyme A binding domain containing 5 |
chr4_+_138694422 | 1.95 |
ENSMUST00000116094.5
ENSMUST00000239443.2 |
Rnf186
|
ring finger protein 186 |
chr9_+_74883377 | 1.94 |
ENSMUST00000081746.7
|
Fam214a
|
family with sequence similarity 214, member A |
chr1_+_175459559 | 1.93 |
ENSMUST00000040250.15
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr5_+_89175815 | 1.93 |
ENSMUST00000130041.8
|
Slc4a4
|
solute carrier family 4 (anion exchanger), member 4 |
chr2_-_69542805 | 1.92 |
ENSMUST00000102706.4
ENSMUST00000073152.13 |
Fastkd1
|
FAST kinase domains 1 |
chr15_+_31224616 | 1.92 |
ENSMUST00000186547.7
|
Dap
|
death-associated protein |
chr11_-_99213769 | 1.91 |
ENSMUST00000038004.3
|
Krt25
|
keratin 25 |
chr6_+_138117519 | 1.90 |
ENSMUST00000120939.8
ENSMUST00000204628.3 ENSMUST00000140932.2 ENSMUST00000120302.8 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr14_-_64654592 | 1.90 |
ENSMUST00000210363.2
|
Msra
|
methionine sulfoxide reductase A |
chr4_-_82623972 | 1.89 |
ENSMUST00000155821.2
|
Nfib
|
nuclear factor I/B |
chr2_-_63014622 | 1.89 |
ENSMUST00000075052.10
ENSMUST00000112454.8 |
Kcnh7
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
chr3_-_85648696 | 1.89 |
ENSMUST00000094148.6
|
Fam160a1
|
family with sequence similarity 160, member A1 |
chr4_+_97665992 | 1.89 |
ENSMUST00000107062.9
ENSMUST00000052018.12 ENSMUST00000107057.8 |
Nfia
|
nuclear factor I/A |
chr14_+_36776775 | 1.88 |
ENSMUST00000120052.2
|
Lrit1
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1 |
chr7_-_79392763 | 1.86 |
ENSMUST00000032761.8
|
Pex11a
|
peroxisomal biogenesis factor 11 alpha |
chr2_-_77533596 | 1.85 |
ENSMUST00000171063.8
|
Zfp385b
|
zinc finger protein 385B |
chr15_+_65682066 | 1.84 |
ENSMUST00000211878.2
|
Efr3a
|
EFR3 homolog A |
chr14_+_28233301 | 1.83 |
ENSMUST00000112272.2
|
Wnt5a
|
wingless-type MMTV integration site family, member 5A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 23.5 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.3 | 7.0 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
2.2 | 8.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
2.1 | 6.4 | GO:1903699 | tarsal gland development(GO:1903699) |
1.9 | 15.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.8 | 11.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.8 | 5.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
1.7 | 25.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.6 | 6.2 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.5 | 13.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.5 | 1.5 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
1.3 | 4.0 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) |
1.2 | 8.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.1 | 3.4 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
1.1 | 1.1 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
1.1 | 4.3 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
1.0 | 3.1 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
1.0 | 7.8 | GO:0000050 | urea cycle(GO:0000050) |
1.0 | 6.8 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 11.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.9 | 3.7 | GO:2000795 | lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.9 | 6.1 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.9 | 2.6 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.8 | 3.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.8 | 5.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 2.3 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.7 | 2.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 4.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 3.6 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 2.1 | GO:1904499 | regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.7 | 3.4 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 2.0 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.7 | 6.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.7 | 10.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.6 | 1.8 | GO:0061348 | chemorepulsion of dopaminergic neuron axon(GO:0036518) cervix development(GO:0060067) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) melanocyte proliferation(GO:0097325) regulation of cell proliferation in midbrain(GO:1904933) |
0.6 | 5.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 9.1 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 4.2 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.6 | 2.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 4.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.6 | 5.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 2.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.6 | 1.7 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.6 | 1.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 5.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.6 | 3.4 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.6 | 0.6 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.6 | 2.2 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.5 | 2.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 2.2 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.5 | 4.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 1.6 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.5 | 6.3 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 2.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 4.7 | GO:0061709 | reticulophagy(GO:0061709) |
0.5 | 3.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 1.5 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.5 | 2.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 4.3 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 1.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.5 | 1.9 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.5 | 3.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.4 | GO:0009087 | methionine catabolic process(GO:0009087) |
0.5 | 13.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 2.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.4 | 3.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 4.8 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.4 | 4.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 6.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 1.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 4.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 8.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.4 | 0.8 | GO:0019627 | urea metabolic process(GO:0019627) |
0.4 | 9.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 1.7 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.4 | 2.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 2.5 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.4 | 2.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.4 | 1.2 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.4 | 1.2 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 1.2 | GO:0014878 | positive regulation of muscle atrophy(GO:0014737) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 0.8 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.4 | 1.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 5.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.4 | 1.6 | GO:0045632 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.4 | 2.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.4 | 2.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 11.6 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.4 | 0.8 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.4 | 1.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 0.4 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.4 | 4.9 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 1.5 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
0.4 | 1.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 2.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 1.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 4.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 1.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 22.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 7.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.1 | GO:0097115 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
0.4 | 1.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.4 | 1.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.4 | 1.8 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.4 | 1.1 | GO:1904635 | glomerular visceral epithelial cell apoptotic process(GO:1903210) regulation of glomerular visceral epithelial cell apoptotic process(GO:1904633) positive regulation of glomerular visceral epithelial cell apoptotic process(GO:1904635) positive regulation of progesterone biosynthetic process(GO:2000184) |
0.4 | 3.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.4 | 2.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 1.1 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.4 | 1.4 | GO:0071110 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.4 | 2.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 1.0 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.3 | 7.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 2.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.3 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.3 | 2.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 1.0 | GO:2000011 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
0.3 | 1.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.3 | 0.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 6.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 1.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 11.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 0.3 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.3 | 3.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 0.9 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.3 | 1.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 3.4 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 0.9 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.3 | 1.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 6.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 0.9 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.3 | 2.1 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.3 | 0.9 | GO:0001966 | thigmotaxis(GO:0001966) |
0.3 | 1.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 3.2 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 0.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.3 | 0.9 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.3 | 1.7 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.3 | 0.8 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 1.1 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.3 | 0.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 1.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 1.9 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.3 | 0.8 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.3 | 14.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.8 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 1.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.3 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.0 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.3 | 2.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 1.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 4.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.7 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.2 | 1.0 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.2 | 3.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 3.7 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 7.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 1.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.7 | GO:0060715 | Spemann organizer formation(GO:0060061) syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.2 | 0.9 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 0.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 2.7 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.2 | 1.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.2 | 1.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 3.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.2 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.2 | 1.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 1.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 4.8 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 2.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 1.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.8 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.2 | 1.5 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 1.0 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.4 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 2.5 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 3.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.6 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.2 | 1.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 1.0 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.2 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 3.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 1.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 7.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 1.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.6 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 1.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 3.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 1.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 9.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.6 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) forebrain anterior/posterior pattern specification(GO:0021797) neuroblast migration(GO:0097402) |
0.2 | 1.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 0.7 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.2 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.9 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.5 | GO:0002396 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.5 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.4 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 0.2 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.2 | 0.4 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 1.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 5.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 1.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.2 | 0.5 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.2 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 0.5 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.2 | 0.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 3.4 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
0.2 | 1.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 2.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.7 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.2 | 1.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 3.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.5 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 3.4 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.8 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 1.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 1.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.9 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.2 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.5 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.2 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 9.9 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 1.2 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 5.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.9 | GO:0097393 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.1 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 1.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 5.5 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 1.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 1.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.3 | GO:0060003 | copper ion export(GO:0060003) |
0.1 | 1.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.7 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 1.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.7 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 2.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 1.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 1.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 1.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.4 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.1 | 0.7 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 0.4 | GO:0021594 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.1 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 1.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.6 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 2.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 3.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 1.0 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 1.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 3.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.8 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.1 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 3.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 1.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.5 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 1.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 4.4 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 2.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 2.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 1.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 1.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.4 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.5 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.6 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 1.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 1.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 2.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.2 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.1 | 2.1 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 2.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 1.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.6 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.1 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.9 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 6.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 4.4 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 2.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 2.8 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.4 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.3 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.7 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 1.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.6 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 1.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.2 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.1 | 0.6 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 1.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.4 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.6 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 1.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.3 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 1.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 1.1 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.1 | 0.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 1.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0072755 | cellular response to benomyl(GO:0072755) response to benomyl(GO:1901561) |
0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 1.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.8 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.5 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.1 | 1.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 1.8 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.4 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.3 | GO:1904826 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
0.1 | 1.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 1.9 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 2.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 1.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.0 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 1.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 0.3 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.8 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 5.7 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 1.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:1902739 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 3.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.2 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 1.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 4.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 1.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 1.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.1 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.7 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 1.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 3.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.4 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.6 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.4 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 0.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 2.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.6 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.6 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 5.6 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 1.2 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 2.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.7 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 1.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.2 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.1 | 6.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 4.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 3.8 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 1.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.1 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.3 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 2.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.3 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.7 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 1.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 3.8 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.5 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 1.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 1.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 7.2 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 0.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 2.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.4 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.0 | 0.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.0 | 0.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 1.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 3.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 1.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 1.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 1.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.3 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 1.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.9 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.0 | 0.3 | GO:0071322 | cellular response to carbohydrate stimulus(GO:0071322) |
0.0 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 1.3 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.0 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 1.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 2.2 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 1.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
0.0 | 0.5 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.0 | 0.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 1.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 1.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.7 | GO:0072164 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.0 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 0.3 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.0 | 0.2 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.9 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.6 | GO:0001656 | metanephros development(GO:0001656) |
0.0 | 0.7 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.0 | 0.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 1.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.4 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 0.8 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 1.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 3.4 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.1 | GO:0021544 | subpallium development(GO:0021544) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 1.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.8 | GO:0051497 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.2 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 5.0 | GO:0015833 | peptide transport(GO:0015833) |
0.0 | 0.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.0 | 0.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.3 | GO:0046638 | positive regulation of alpha-beta T cell differentiation(GO:0046638) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 1.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 1.4 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 1.9 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.4 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.2 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.0 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.7 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.0 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.0 | 0.2 | GO:0007595 | lactation(GO:0007595) |
0.0 | 0.3 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 23.3 | GO:0005579 | membrane attack complex(GO:0005579) |
2.4 | 23.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 6.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 2.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.6 | 11.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.6 | 14.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 2.6 | GO:0034657 | GID complex(GO:0034657) |
0.4 | 4.3 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.4 | 30.0 | GO:0070469 | respiratory chain(GO:0070469) |
0.4 | 4.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 4.0 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 1.1 | GO:1990843 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.4 | 1.8 | GO:0035841 | new growing cell tip(GO:0035841) |
0.3 | 10.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 5.7 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.3 | 1.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 0.3 | GO:1904602 | serotonin-activated cation-selective channel complex(GO:1904602) |
0.3 | 2.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 2.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.3 | 0.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.3 | 1.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.3 | 1.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.3 | 1.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.9 | GO:0034683 | integrin alphav-beta3 complex(GO:0034683) integrin alphav-beta8 complex(GO:0034686) |
0.2 | 0.7 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.2 | 7.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.6 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.2 | 1.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 3.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 5.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 5.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 3.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 4.7 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 3.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 2.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.6 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.2 | 5.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 5.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 1.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.8 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.2 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 2.6 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.2 | 0.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 0.9 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.1 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 2.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.1 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 2.0 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 8.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 2.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 5.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 20.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 2.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 1.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 3.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 7.9 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 2.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 3.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 9.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.0 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.6 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 4.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0090537 | CERF complex(GO:0090537) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 2.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0070992 | translation initiation complex(GO:0070992) |
0.1 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 2.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 1.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 2.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.0 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 2.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 12.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.0 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 2.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 4.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 4.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 3.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 11.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 9.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 1.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 5.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 4.6 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 3.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 2.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 19.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 1.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 3.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 3.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 2.1 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.0 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 1.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 10.9 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 2.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 6.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 9.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 4.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 3.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 10.2 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.5 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 2.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.0 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.8 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 19.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 1.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 4.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 4.2 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
2.9 | 8.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.9 | 11.6 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
2.2 | 13.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.8 | 5.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.8 | 7.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.6 | 6.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
1.3 | 8.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.1 | 4.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.1 | 3.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
1.1 | 3.2 | GO:0008431 | vitamin E binding(GO:0008431) |
1.1 | 6.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.0 | 4.2 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.9 | 29.0 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.9 | 3.7 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.9 | 6.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.9 | 2.7 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.9 | 3.6 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.9 | 3.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.8 | 8.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 4.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 3.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.8 | 4.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.7 | 0.7 | GO:0035276 | ethanol binding(GO:0035276) |
0.7 | 2.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 5.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 2.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.7 | 8.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.6 | 18.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 2.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.6 | 1.8 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.6 | 1.8 | GO:0008127 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) quercetin 2,3-dioxygenase activity(GO:0008127) |
0.6 | 3.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.5 | 4.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.5 | 9.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 1.6 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.5 | 6.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 2.6 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.5 | 1.5 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.5 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 5.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 5.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 10.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.5 | 1.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.5 | 21.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 2.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.5 | 14.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 8.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.5 | 1.8 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.5 | 1.8 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.4 | 1.3 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.4 | 5.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 1.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 5.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 6.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.4 | 1.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 1.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.4 | 15.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.4 | 1.4 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.3 | 1.4 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.3 | 3.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 6.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 1.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.3 | 6.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 4.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 3.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 5.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 1.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.3 | 1.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 4.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.9 | GO:0070540 | stearic acid binding(GO:0070540) |
0.3 | 0.9 | GO:0001571 | non-tyrosine kinase fibroblast growth factor receptor activity(GO:0001571) |
0.3 | 21.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 2.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 0.9 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.3 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 3.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 2.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.3 | 1.0 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.3 | 1.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 1.6 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.2 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 3.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 1.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 3.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 4.7 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 2.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 8.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 1.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 0.6 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.2 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 2.2 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
0.2 | 4.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 5.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 1.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 3.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 4.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 1.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 1.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 0.5 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.2 | 0.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 3.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 6.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 7.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 2.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.2 | 1.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.5 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.2 | 0.6 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 1.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 5.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 1.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.2 | 6.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 5.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 4.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 5.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 1.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 4.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.5 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 7.4 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 2.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 1.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 2.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 1.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.7 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.3 | GO:0071820 | N-box binding(GO:0071820) |
0.1 | 6.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 1.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.6 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 3.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 1.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.5 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 3.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.1 | 0.7 | GO:0008158 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.1 | 2.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 7.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 15.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 1.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 1.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.2 | GO:0099530 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.1 | 0.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 3.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 1.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.3 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.1 | 2.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 1.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 3.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 3.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 3.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 4.5 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 3.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 1.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 2.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.4 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.9 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 12.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 10.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 7.5 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 1.6 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.1 | 1.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 2.2 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 2.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 2.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 1.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.0 | 1.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 1.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 2.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.3 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 1.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 1.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
0.0 | 0.3 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 1.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 1.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 1.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.0 | 1.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 3.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 1.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 1.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 1.5 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 2.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.0 | 1.4 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.0 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.0 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 1.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.0 | 2.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 1.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 32.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 33.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 13.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 10.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 5.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 10.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 12.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 6.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 5.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 4.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 6.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 7.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 3.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 4.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 3.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 5.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 8.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 3.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 2.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 33.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.9 | 13.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 7.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 7.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 6.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 5.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 15.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 8.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 4.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 1.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 27.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 7.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 5.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 3.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 7.9 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 3.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 0.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 8.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 6.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 11.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 8.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 5.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 4.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 5.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 3.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 3.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 3.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 5.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 5.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 3.0 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 4.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 11.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 2.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 4.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 1.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 2.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 1.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 1.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.6 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |